Catalyst Wire Dossier Catalyst Wire Dossier

SRP-1005

· Sarepta Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRP-1005, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease [Phase 1]

See pricing